Triple-negative breast cancer (TNBC), a subtype of breast cancer, is defined as lacking
estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor …

Pancreatic cancer is one of the most lethal solid organ tumors. Due to the rising incidence,
late diagnosis, and limited treatment options, it is expected to be the second leading cause …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a
dismal prognosis. While immunotherapy has been deemed a breakthrough treatment for …

Peptide-based cancer vaccines are widely investigated in the clinic but exhibit modest
immunogenicity. One approach that has been explored to enhance peptide vaccine potency …

Pancreatic cancer is considered to be one of the most aggressive cancers. For unknown
reasons, the incidence of pancreatic cancer is slowly rising and so too are mortality rates …

Pancreatic ductal adenocarcinoma (PDAC) is an incurable lethal disease whose incidence
rate is growing. There is no effective screening for detection of early stage tumors and, in …

With the approval of the first therapeutic cancer vaccine by US Food and Drug
Administration, numerous therapeutic cancer vaccines have been under clinical trials with …

The genomic-plasticity of the immune system creates a broad immune repertoire engaged to
tackle cancer cells. Promising clinical activity has been observed with several immune …

Malignant cells express antigens that can be harnessed to elicit anticancer immune
responses. One approach to achieve such goal consists in the administration of tumor …

Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of
pancreatic cancer and has abysmal survival rates. In the past two decades …